CN110787074A - Composition for fading fine lines - Google Patents

Composition for fading fine lines Download PDF

Info

Publication number
CN110787074A
CN110787074A CN201911017454.9A CN201911017454A CN110787074A CN 110787074 A CN110787074 A CN 110787074A CN 201911017454 A CN201911017454 A CN 201911017454A CN 110787074 A CN110787074 A CN 110787074A
Authority
CN
China
Prior art keywords
component
percent
butanediol
water
glycerol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201911017454.9A
Other languages
Chinese (zh)
Inventor
石毛
林志隆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ANGLEE COSMETIC TECHNOLOGY Co Ltd
Original Assignee
ANGLEE COSMETIC TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ANGLEE COSMETIC TECHNOLOGY Co Ltd filed Critical ANGLEE COSMETIC TECHNOLOGY Co Ltd
Priority to CN201911017454.9A priority Critical patent/CN110787074A/en
Publication of CN110787074A publication Critical patent/CN110787074A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • A61K8/988Honey; Royal jelly, Propolis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)

Abstract

The invention discloses a composition for fading fine wrinkles, which mainly contains multiple active ingredients such as hydrolytic yeast extract, wild soybean seed extract, euglena gracilis polysaccharide, royal jelly extract and the like, and is compounded for use. The composition for fading fine wrinkles can promote skin to be better absorbed, is beneficial to skin damage repair, nourishes skin, supplements skin moisture, consolidates repair effect, reduces the proportion of irritant substances, and makes the product safer and more reliable. The invention can be widely applied to skin care products such as eye cream, eye patches and the like.

Description

Composition for fading fine lines
Technical Field
The invention belongs to the field of skin care products, and particularly relates to a composition for fading fine lines.
Background
The fine lines and wrinkles of the eyes are formed by that the skin of the eyes is affected by the external environment to form free radicals, the free radicals destroy collagen and active substances in normal cell membrane tissues and oxidize cells. 1. Among facial skins, skin around eyes is thinnest with a thickness of only 0.4 mm due to insufficient moisture. Because of this part of the skin, it has no sebaceous glands, sweat glands, and is very thin. Therefore, the skin around the eyes has a weak protective function, and in addition, moisture in the skin around the eyes is easily evaporated, and when the moisture retention capacity is poor, dryness becomes the most likely problem. 2. Excessive use of eyes, long-term computer facing and various bad habits such as frequent squinting or blinking can easily cause the aging of eye skin and fine lines. 3. Blood circulation is not good, and because the skin of the eye is thin, blood vessels in the opposite skin are thin and few, so that it is difficult to transport nutrients and oxygen into skin cells, and capillary circulation around the eye is easy to stagnate.
Skin care products or cosmetics in the market are mainly for the face, and products specially used for fading fine lines of eyes and nursing the skin of the eyes are few, the effect is still not ideal, and users still need a safe and efficient eye skin nursing product.
Disclosure of Invention
The invention aims to provide a composition with a fine line fading function
The technical scheme adopted by the invention is as follows: a fine grain reduction composition, said fine grain reduction composition consisting of A, B, C, D, E, F, G, H, I, J, K, L, M components; wherein:
the component A is prepared from water, dipropylene glycol, isohexadecane, caprylic/capric triglyceride, hydrogenated coconut oil glyceride, butanediol, propylene glycol, glycerol, stearyl alcohol, shea butter, mineral oil, polydimethylsiloxane, pulvis Talci, stearic acid, PEG-60 glyceryl isostearate, behenyl alcohol, glucosyl hesperidin, 1, 2-pentanediol, trehalose, and silica, panthenol, cholesteryl hydroxy-stearic acid ester, carnosine, tocopherol acetate, allantoin, phenoxyethanol, potassium cetyl phosphate, triethanolamine, acrylic acid or esters/C10-30 alkanol acrylate crosspolymer, caprylyl glycol, EDTA-disodium, sodium hyaluronate, resveratrol, rosa damascena flower extract, essence, a colorant CI75470, a colorant CI 15985, a colorant CI19140, and a colorant CI 17200;
the component B consists of arachidyl alcohol, behenyl alcohol and arachidyl alcohol glucoside;
the component C comprises a split yeast fermentation product filtrate, caprylyl hydroximic acid, propylene glycol, glyceryl caprylate and phenoxyethanol;
the component D consists of butanediol and a hydrolytic yeast extract;
the component E consists of hydroxyphenylpropionamide benzoic acid, ascorbyl palmitate, butanediol, 1, 2-pentanediol,
The component F comprises semen glycines extract and glycerol;
the G component consists of euglena gracilis polysaccharide and hydrolyzed collagen;
the H component comprises water, palmitoyl oligopeptide, palmitoyl tetrapeptide-7, butanediol, carbomer, glycerol and polysorbate-20;
the component I comprises water, hydrolyzed elastin, citric acid, tropolone, polysorbate-20, octyl glycol, ethylhexyl glycerin and 1, 2-hexanediol;
the J component consists of water, palmitoyl pentapeptide-4, glycerol, butanediol, carbomer and polysorbate-20;
the component K consists of water, ceramide 3, caprylic/capric triglyceride, cholesterol, hydrogenated lecithin, phytosphingosine, stearic acid, oleic acid and lactic acid;
the L component comprises apple fruit cell culture extract, glycerol, lecithin, xanthan gum and phenoxyethanol;
the M component comprises water, butanediol, and Lac Regis Apis extract.
The composition for fading fine lines comprises the following components in percentage by weight:
the component A comprises 50-72% of water, 3-65% of dipropylene glycol, 2-5% of isohexadecane, 2-6% of caprylic/capric triglyceride, 2-4% of cocoglycerides, 1-4% of butanediol, 1-3% of propylene glycol, 1-3% of glycerol, 1-4% of stearyl alcohol, 1-2% of shea butter, 1-3% of mineral oil, 1-3% of polydimethylsiloxane, 0.5-2% of talcum powder, 0.3-2% of stearic acid, 0.5-2% of PEG-60 glyceryl isostearate, 0.3-2% of behenyl alcohol, 0.5-2% of glucosyl hesperidin, 0.3-1% of 1, 2-pentanediol, 0.2-0.8% of trehalose, 0.2-1.2% of silica, 2-1.2% of glycerol, and a mixture of a solvent, wherein the components are mixed together to obtain a mixture, 0.2-1.5% panthenol, 0.1-0.5% cholesteryl hydroxy stearic acid ester, 0.1-1% carnosine, 0.1-1% tocopherol acetate, 0.02-0.5% allantoin, 0.3-0.6% phenoxyethanol, 0.1-0.5% potassium cetyl phosphate, 0.2-0.5% triethanolamine, 0.1-0.5% acrylic acid or ester/C10-30 alkanol acrylate crosspolymer, 0.1-0.4% caprylyl glycol, 0.05-0.2% of EDTA-disodium, 0.001-0.005% of sodium hyaluronate, 0.0001-0.02% of resveratrol, 0.0001-0.01% of rosa damascena flower extract, 0.1-0.2% of essence, 0.00001-0.00002% of colorant CI75470, 0.00003-0.00006% of colorant CI 15985, 0.00001-0.00003% of colorant CI19140 and 0.00001-0.00002% of colorant CI 17200;
the component B consists of arachidyl alcohol, behenyl alcohol and arachidyl glucoside, and accounts for 1-4% of the total;
the component C comprises 1-3% of a secondary fission yeast fermentation product filtrate, caprylyl hydroximic acid, propylene glycol, glyceryl caprylate and phenoxyethanol;
the component D comprises butanediol and hydrolytic yeast extract, accounting for 0.2-2% of the total;
the component E consists of hydroxyphenyl propionamide benzoic acid, ascorbyl palmitate, butanediol and 1, 2-pentanediol, and accounts for 0.1-0.5% of the total;
the component F comprises semen glycines extract and glycerol, and accounts for 0.05-0.5%;
the G component consists of euglena gracilis polysaccharide and hydrolyzed collagen, and accounts for 0.01-0.5% of the total;
the H component consists of water, palmitoyl oligopeptide, palmitoyl tetrapeptide-7, butanediol, carbomer, glycerol and polysorbate-20, and accounts for 0.001-0.5%;
the component I comprises water, hydrolyzed elastin, citric acid, tropolone, polysorbate-20, octyl glycol, ethylhexyl glycerol, and 1, 2-hexanediol, and accounts for 0.001-0.3%;
the J component consists of water, palmitoyl pentapeptide-4, glycerol, butanediol, carbomer and polysorbate-20, and accounts for 0.001-2%;
the component K consists of water, ceramide 3, caprylic/capric triglyceride, cholesterol, hydrogenated lecithin, phytosphingosine, stearic acid, oleic acid and lactic acid, and accounts for 0.001-0.5% of the total;
the L component comprises apple fruit cell culture extract, glycerol, lecithin, xanthan gum and phenoxyethanol, and accounts for 0.001-0.5% of the total;
the M component comprises water, butanediol, and Lac Regis Apis extract, and accounts for 0.001-0.2% of the total amount.
The sum of the components A to M is 100%.
In some embodiments, the fine line fading composition consists of the following weight percentages:
the component A comprises 54.435893% of water, 5% of dipropylene glycol, 4% of isohexadecane, 4% of caprylic/capric triglyceride, 3% of cocoglycerides, 2% of butanediol, 2% of propylene glycol, 2% of glycerol, 2% of stearyl alcohol, 2% of shea butter, 2% of mineral oil, 2% of polydimethylsiloxane, 1% of talcum powder, 1% of stearic acid, 1% of PEG-60 glyceryl isostearate, 1% of behenyl alcohol, 1% of glucosyl hesperidin, 0.5% of 1, 2-pentanediol, 0.5% of trehalose, 0.5% of silica, 0.5% of panthenol, 0.3% of cholesteryl hydroxy stearic acid ester, 0.3% of carnosine, 0.3% of tocopheryl acetate, 0.3% of allantoin, 0.3% of phenoxyethanol, 0.2% of cetyl alcohol phosphate, 0.2% of triethanolamine acrylate, 0.2% of acrylic acid ester 10% of cross-linked polymer of C30-32C-C.3% of acrylic acid, 0.2% of caprylyl glycol, 0.1% of EDTA-disodium, 0.003% of sodium hyaluronate, 0.0005% of resveratrol, 0.0005% of rosa damascena flower extract, 0.1% of essence, 0.00002% of colorant CI75470, 0.00003% of colorant CI 15985, 0.00001% of colorant CI19140 and 0.00001% of colorant CI 17200;
the component B consists of 0.5 percent of arachidyl alcohol, 0.5 percent of behenyl alcohol and 0.5 percent of arachidyl alcohol glucoside;
the component C comprises 0.01% of a fermentation product filtrate of the yeast schizosaccharomyces, 0.1% of caprylyl hydroximic acid, 1% of propylene glycol, 0.1% of glyceryl caprylate and 0.1% of phenoxyethanol;
the component D comprises 0.5% of butanediol and 0.1% of hydrolytic yeast extract;
the component E consists of 0.05 percent of hydroxyphenylpropionamide benzoic acid, 0.05 percent of ascorbyl palmitate, 0.1 percent of butanediol and 0.1 percent of 1, 2-pentanediol;
the component F comprises 0.05% of extract of semen glycines and 0.2% of glycerol;
the G component consists of 0.05 percent of euglena gracilis polysaccharide and 0.05 percent of hydrolyzed collagen;
the H component comprises 0.2% of water, 0.005% of palmitoyl oligopeptide, 0.005% of palmitoyl tetrapeptide-7, 0.005% of butanediol, 0.1% of carbomer, 0.1% of glycerol and 0.005% of polysorbate-20;
component I consists of 0.05% of water, 0.0005% of hydrolyzed elastin, 0.1% of citric acid, 0.0005% of tropolone, 0.005% of polysorbate-20, 0.02% of caprylyl glycol, 0.02% of ethylhexyl glycerin, 0.05% of 1, 2-hexanediol;
the J component consists of 0.5% of water, 0.005% of palmitoyl pentapeptide-4, 0.5% of glycerin, 0.005% of butanediol, 0.05% of carbomer and 0.05% of polysorbate-20;
the K component consists of 0.05 percent of water, 0.005 percent of ceramide 3, 0.05 percent of caprylic/capric triglyceride, 0.005 percent of cholesterol, 0.005 percent of hydrogenated lecithin, 0.005 percent of phytosphingosine, 0.01 percent of stearic acid, 0.01 percent of oleic acid and 0.01 percent of lactic acid;
the L component comprises 0.05% of apple fruit cell culture extract, 0.01% of glycerol, 0.01% of lecithin, 0.01% of xanthan gum and 0.01% of phenoxyethanol;
the M component comprises 0.1% of water, 0.05% of butanediol, and 0.01% of royal jelly extract.
The preparation method of the composition for fading the fine lines comprises the following steps:
1) weighing the component A into a water phase pot, stirring and heating;
2) weighing the components B to M, and respectively stirring and mixing for later use;
3) adding the component A, stirring and heating to 80-85 ℃, placing in an emulsifying pot, vacuumizing to 500pa, stirring at 20rpm, emulsifying at 3200rpm, after vacuum emulsification for 5 minutes, beginning to stir, cooling to 50 ℃, adding B, C, D, E items, stirring and cooling to 40 ℃ after vacuum stirring for 3 minutes, adding the component F, G, H, I, J, K, L, M, and vacuum emulsification for 2 minutes, thus discharging.
The invention has the beneficial effects that: the invention combines and uses a plurality of active ingredients such as hydrolytic yeast extract, wild soybean seed extract, euglena gracilis polysaccharide, royal jelly extract, and the like, thereby not only promoting better absorption of skin and being beneficial to the damage repair of skin, but also nourishing skin, supplementing skin moisture, consolidating the repair effect, reducing the proportion of irritant substances and ensuring that the product is safer and more reliable. The invention can be widely applied to skin care products such as eye cream, eye patches and the like.
Detailed Description
The invention will be further illustrated with reference to specific examples.
The composition for reducing fine lines in the examples consisted of A, B, C, D, E, F, G, H, I, J, K, L, M components. The proportioning percentage is as follows:
the component A comprises 50-72% of water, 3-65% of dipropylene glycol, 2-5% of isohexadecane, 2-6% of caprylic/capric triglyceride, 2-4% of cocoglycerides, 1-4% of butanediol, 1-3% of propylene glycol, 1-3% of glycerol, 1-4% of stearyl alcohol, 1-2% of shea butter, 1-3% of mineral oil, 1-3% of polydimethylsiloxane, 0.5-2% of talcum powder, 0.3-2% of stearic acid, 0.5-2% of PEG-60 glyceryl isostearate, 0.3-2% of behenyl alcohol, 0.5-2% of glucosyl hesperidin, 0.3-1% of 1, 2-pentanediol, 0.2-0.8% of trehalose, 0.2-1.2% of silica, 2-1.2% of glycerol, and a mixture of a solvent, wherein the components are mixed together to obtain a mixture, 0.2-1.5% panthenol, 0.1-0.5% cholesteryl hydroxy stearic acid ester, 0.1-1% carnosine, 0.1-1% tocopherol acetate, 0.02-0.5% allantoin, 0.3-0.6% phenoxyethanol, 0.1-0.5% potassium cetyl phosphate, 0.2-0.5% triethanolamine, 0.1-0.5% acrylic acid or ester/C10-30 alkanol acrylate crosspolymer, 0.1-0.4% caprylyl glycol, 0.05-0.2% of EDTA-disodium, 0.001-0.005% of sodium hyaluronate, 0.0001-0.02% of resveratrol, 0.0001-0.01% of rosa damascena flower extract, 0.1-0.2% of essence, 0.00001-0.00002% of colorant CI75470, 0.00003-0.00006% of colorant CI 15985, 0.00001-0.00003% of colorant CI19140 and 0.00001-0.00002% of colorant CI 17200;
the component B consists of arachidyl alcohol, behenyl alcohol and arachidyl glucoside, and accounts for 1-4% of the total;
the component C comprises 1-3% of a secondary fission yeast fermentation product filtrate, caprylyl hydroximic acid, propylene glycol, glyceryl caprylate and phenoxyethanol;
the component D comprises butanediol and hydrolytic yeast extract, accounting for 0.2-2% of the total;
the component E consists of hydroxyphenyl propionamide benzoic acid, ascorbyl palmitate, butanediol and 1, 2-pentanediol, and accounts for 0.1-0.5% of the total;
the component F comprises semen glycines extract and glycerol, and accounts for 0.05-0.5%;
the G component consists of euglena gracilis polysaccharide and hydrolyzed collagen, and accounts for 0.01-0.5% of the total;
the H component consists of water, palmitoyl oligopeptide, palmitoyl tetrapeptide-7, butanediol, carbomer, glycerol and polysorbate-20, and accounts for 0.001-0.5%;
the component I comprises water, hydrolyzed elastin, citric acid, tropolone, polysorbate-20, octyl glycol, ethylhexyl glycerol, and 1, 2-hexanediol, and accounts for 0.001-0.3%;
the J component consists of water, palmitoyl pentapeptide-4, glycerol, butanediol, carbomer and polysorbate-20, and accounts for 0.001-2%;
the component K consists of water, ceramide 3, caprylic/capric triglyceride, cholesterol, hydrogenated lecithin, phytosphingosine, stearic acid, oleic acid and lactic acid, and accounts for 0.001-0.5% of the total;
the L component comprises apple fruit cell culture extract, glycerol, lecithin, xanthan gum and phenoxyethanol, and accounts for 0.001-0.5% of the total;
the M component comprises water, butanediol, and Lac Regis Apis extract, and accounts for 0.001-0.2% of the total amount.
The preparation method of the composition for fading the fine lines comprises the following steps:
1) weighing the component A into a water phase pot, stirring and heating;
2) weighing the components B to M, and respectively stirring and mixing for later use;
3) adding the component A, stirring and heating to 80-85 ℃, placing in an emulsifying pot, vacuumizing to 500pa, stirring at 20rpm, emulsifying at 3200rpm, after vacuum emulsification for 5 minutes, beginning to stir, cooling to 50 ℃, adding B, C, D, E items, stirring and cooling to 40 ℃ after vacuum stirring for 3 minutes, adding the component F, G, H, I, J, K, L, M, and vacuum emulsification for 2 minutes, thus discharging.
Example 1:
the component A comprises 54.435893% of water, 5% of dipropylene glycol, 4% of isohexadecane, 4% of caprylic/capric triglyceride, 3% of cocoglycerides, 2% of butanediol, 2% of propylene glycol, 2% of glycerol, 2% of stearyl alcohol, 2% of shea butter, 2% of mineral oil, 2% of polydimethylsiloxane, 1% of talcum powder, 1% of stearic acid, 1% of PEG-60 glyceryl isostearate, 1% of behenyl alcohol, 1% of glucosyl hesperidin, 0.5% of 1, 2-pentanediol, 0.5% of trehalose, 0.5% of silica, 0.5% of panthenol, 0.3% of cholesteryl hydroxy stearic acid ester, 0.3% of carnosine, 0.3% of tocopheryl acetate, 0.3% of allantoin, 0.3% of phenoxyethanol, 0.2% of cetyl alcohol phosphate, 0.2% of triethanolamine acrylate, 0.2% of acrylic acid ester 10% of cross-linked polymer of C30-32C-C.3% of acrylic acid, 0.2% of caprylyl glycol, 0.1% of EDTA-disodium, 0.003% of sodium hyaluronate, 0.0005% of resveratrol, 0.0005% of rosa damascena flower extract, 0.1% of essence, 0.00002% of colorant CI75470, 0.00003% of colorant CI 15985, 0.00001% of colorant CI19140 and 0.00001% of colorant CI 17200;
the component B consists of 0.5 percent of arachidyl alcohol, 0.5 percent of behenyl alcohol and 0.5 percent of arachidyl alcohol glucoside;
the component C comprises 0.01% of a fermentation product filtrate of the yeast schizosaccharomyces, 0.1% of caprylyl hydroximic acid, 1% of propylene glycol, 0.1% of glyceryl caprylate and 0.1% of phenoxyethanol;
the component D comprises 0.5% of butanediol and 0.1% of hydrolytic yeast extract;
the component E consists of 0.05 percent of hydroxyphenylpropionamide benzoic acid, 0.05 percent of ascorbyl palmitate, 0.1 percent of butanediol and 0.1 percent of 1, 2-pentanediol;
the component F comprises 0.05% of extract of semen glycines and 0.2% of glycerol;
the G component consists of 0.05 percent of euglena gracilis polysaccharide and 0.05 percent of hydrolyzed collagen;
the H component comprises 0.2% of water, 0.005% of palmitoyl oligopeptide, 0.005% of palmitoyl tetrapeptide-7, 0.005% of butanediol, 0.1% of carbomer, 0.1% of glycerol and 0.005% of polysorbate-20;
component I consists of 0.05% of water, 0.0005% of hydrolyzed elastin, 0.1% of citric acid, 0.0005% of tropolone, 0.005% of polysorbate-20, 0.02% of caprylyl glycol, 0.02% of ethylhexyl glycerin, 0.05% of 1, 2-hexanediol;
the J component consists of 0.5% of water, 0.005% of palmitoyl pentapeptide-4, 0.5% of glycerin, 0.005% of butanediol, 0.05% of carbomer and 0.05% of polysorbate-20;
the K component consists of 0.05 percent of water, 0.005 percent of ceramide 3, 0.05 percent of caprylic/capric triglyceride, 0.005 percent of cholesterol, 0.005 percent of hydrogenated lecithin, 0.005 percent of phytosphingosine, 0.01 percent of stearic acid, 0.01 percent of oleic acid and 0.01 percent of lactic acid;
the L component comprises 0.05% of apple fruit cell culture extract, 0.01% of glycerol, 0.01% of lecithin, 0.01% of xanthan gum and 0.01% of phenoxyethanol;
the M component comprises 0.1% of water, 0.05% of butanediol, and 0.01% of royal jelly extract.
Example 2:
the component A comprises 54.315893% of water, 5% of dipropylene glycol, 4% of isohexadecane, 4% of caprylic/capric triglyceride, 3% of cocoglycerides, 2% of butanediol, 2% of propylene glycol, 2% of glycerol, 2% of stearyl alcohol, 2% of shea butter, 2% of mineral oil, 2% of polydimethylsiloxane, 1% of talcum powder, 1% of stearic acid, 1% of PEG-60 glyceryl isostearate, 1% of behenyl alcohol, 1% of glucosyl hesperidin, 0.5% of 1, 2-pentanediol, 0.5% of trehalose, 0.5% of silica, 0.5% of panthenol, 0.3% of cholesteryl hydroxy stearic acid ester, 0.3% of carnosine, 0.3% of tocopheryl acetate, 0.3% of allantoin, 0.3% of phenoxyethanol, 0.2% of cetyl alcohol phosphate, 0.2% of triethanolamine acrylate, 0.2% of acrylic acid ester 10% of cross-linked polymer of C30-32C-C.3% of acrylic acid, 0.2% of caprylyl glycol, 0.1% of EDTA-disodium, 0.003% of sodium hyaluronate, 0.0005% of resveratrol, 0.0005% of rosa damascena flower extract, 0.1% of essence, 0.00002% of colorant CI75470, 0.00003% of colorant CI 15985, 0.00001% of colorant CI19140 and 0.00001% of colorant CI 17200;
the component B consists of 0.5 percent of arachidyl alcohol, 0.5 percent of behenyl alcohol and 0.5 percent of arachidyl alcohol glucoside;
the component C comprises 0.01% of a fermentation product filtrate of the yeast schizosaccharomyces, 0.1% of caprylyl hydroximic acid, 1% of propylene glycol, 0.1% of glyceryl caprylate and 0.1% of phenoxyethanol;
the component D comprises 0.5% of butanediol and 0.1% of hydrolytic yeast extract;
the component E consists of 0.05 percent of hydroxyphenylpropionamide benzoic acid, 0.05 percent of ascorbyl palmitate, 0.1 percent of butanediol and 0.1 percent of 1, 2-pentanediol;
the component F comprises 0.05% of extract of semen glycines and 0.2% of glycerol;
the G component consists of 0.1 percent of euglena gracilis polysaccharide and 0.1 percent of hydrolyzed collagen;
the H component comprises 0.2% of water, 0.005% of palmitoyl oligopeptide, 0.005% of palmitoyl tetrapeptide-7, 0.005% of butanediol, 0.1% of carbomer, 0.1% of glycerol and 0.005% of polysorbate-20;
component I consists of 0.05% of water, 0.0005% of hydrolyzed elastin, 0.1% of citric acid, 0.0005% of tropolone, 0.005% of polysorbate-20, 0.02% of caprylyl glycol, 0.02% of ethylhexyl glycerin, 0.05% of 1, 2-hexanediol;
the J component consists of 0.5% of water, 0.005% of palmitoyl pentapeptide-4, 0.5% of glycerin, 0.005% of butanediol, 0.05% of carbomer and 0.05% of polysorbate-20;
the K component consists of 0.05 percent of water, 0.01 percent of ceramide 3, 0.05 percent of caprylic/capric triglyceride, 0.01 percent of cholesterol, 0.01 percent of hydrogenated lecithin, 0.01 percent of phytosphingosine, 0.01 percent of stearic acid, 0.01 percent of oleic acid and 0.01 percent of lactic acid;
the L component comprises 0.05% of apple fruit cell culture extract, 0.1% of glycerol, 0.1% of lecithin, 0.1% of xanthan gum and 0.1% of phenoxyethanol;
the M component comprises 0.1% of water, 0.05% of butanediol, and 0.01% of royal jelly extract.
Example 3:
the antioxidant activity (AOA) was determined for inventive example 1 and comparative example (patent 2004800222529 example 1), AOA representing the coulomb consumption of 100g of the analyzed material, as shown in table 1:
TABLE 1
Inventive example 1 Inventive example 2 Comparative example
AOA,kCb/100g 269.6 265.9 240
As can be seen from Table 1, the AOA value of the cosmetic prepared by the present invention is significantly higher than that of the comparative example, indicating that the cosmetic of the present invention has strong oxidation resistance and can effectively scavenge free radicals.
Skin complexion L values were measured using a Colorimeter CL400, a skin color tester produced by Courage Khazaka (CK) of germany, to evaluate the effect on skin penetration by measuring the change in the L value of the skin before and after use of the product, and three groups of subjects having the same mean value of the initial L values were tested, 10 per group, for a period of 4 weeks, and the results were averaged as shown in table 2:
TABLE 2
Inventive example 1 Inventive example 2 Comparative example
0 week 45.0 45.0 45.0
4 weeks 59.5 58.1 50.3
As can be seen from table 2 above, the L value of the present invention increases at a rate significantly higher than the comparative example after four weeks of use of the product, indicating that the whitening effect of the present invention is significant and the skin brightness is high after use.
Skin hydration was measured to have the same starting mean for three groups of 10 subjects over a four week period, and the results averaged, as in table 3:
TABLE 3
Inventive example 1 Inventive example 2 Comparative example
0 week 23.0 23.0 23.0
4 weeks 37.4 36.9 33.3
As can be seen from table 3 above, the product of the present invention increases the skin hydration rate of the subject rapidly, is significantly superior to the comparative example, and shows that the moisturizing effect of the present invention is good, and can restore dry skin to a state of sufficient moisture.
The above detailed description is specific to one possible embodiment of the present invention, and the embodiment is not intended to limit the scope of the present invention, and all equivalent implementations or modifications without departing from the scope of the present invention should be included in the technical scope of the present invention.

Claims (7)

1. A composition for reducing fine lines, comprising: the fine line fading composition consists of A, B, C, D, E, F, G, H, I, J, K, L, M components; wherein:
component A comprises water, dipropylene glycol, isohexadecane, caprylic/capric triglyceride, hydrogenated cocoglycerides, butylene glycol, propylene glycol, glycerol, stearyl alcohol, shea butter, mineral oil, polydimethylsiloxane, talc, stearic acid, PEG-60 glyceryl isostearate, behenyl alcohol, glucosyl hesperidin, 1, 2-pentanediol, trehalose, silica, panthenol, cholesteryl hydroxy-stearic acid ester, carnosine, tocopheryl acetate, allantoin, phenoxyethanol, potassium cetyl phosphate, triethanolamine, acrylic acid or esters/C10-30 alkanol acrylate crosspolymer, caprylyl glycol, EDTA-disodium, sodium hyaluronate, resveratrol, Rosa damascena extract, essence, colorant CI75470, colorant CI 15985, colorant 19140, and colorant 17200;
the component B consists of arachidyl alcohol, behenyl alcohol and arachidyl alcohol glucoside;
the component C comprises a split yeast fermentation product filtrate, caprylyl hydroximic acid, propylene glycol, glyceryl caprylate and phenoxyethanol;
the component D consists of butanediol and a hydrolytic yeast extract;
the component E consists of hydroxyphenylpropionamide benzoic acid, ascorbyl palmitate, butanediol, 1, 2-pentanediol,
The component F comprises semen glycines extract and glycerol;
the G component consists of euglena gracilis polysaccharide and hydrolyzed collagen;
the H component comprises water, palmitoyl oligopeptide, palmitoyl tetrapeptide-7, butanediol, carbomer, glycerol and polysorbate-20;
the component I comprises water, hydrolyzed elastin, citric acid, tropolone, polysorbate-20, octyl glycol, ethylhexyl glycerin and 1, 2-hexanediol;
the J component consists of water, palmitoyl pentapeptide-4, glycerol, butanediol, carbomer and polysorbate-20;
the component K consists of water, ceramide 3, caprylic/capric triglyceride, cholesterol, hydrogenated lecithin, phytosphingosine, stearic acid, oleic acid and lactic acid;
the L component comprises apple fruit cell culture extract, glycerol, lecithin, xanthan gum and phenoxyethanol;
the M component comprises water, butanediol, and Lac Regis Apis extract.
2. The composition for attenuating fine lines according to claim 1, characterized in that: the composition for fading fine lines comprises the following components in percentage by weight:
the component A comprises 50-72% of water, 3-65% of dipropylene glycol, 2-5% of isohexadecane, 2-6% of caprylic/capric triglyceride, 2-4% of cocoglycerides, 1-4% of butanediol, 1-3% of propylene glycol, 1-3% of glycerol, 1-4% of stearyl alcohol, 1-2% of shea butter, 1-3% of mineral oil, 1-3% of polydimethylsiloxane, 0.5-2% of talcum powder, 0.3-2% of stearic acid, 0.5-2% of PEG-60 glyceryl isostearate, 0.3-2% of behenyl alcohol, 0.5-2% of glucosyl hesperidin, 0.3-1% of 1, 2-pentanediol, 0.2-0.8% of trehalose, 0.2-1.2% of silica, 2-1.2% of glycerol, and a mixture of a solvent, wherein the components are mixed together to obtain a mixture, 0.2-1.5% panthenol, 0.1-0.5% cholesteryl hydroxy stearic acid ester, 0.1-1% carnosine, 0.1-1% tocopherol acetate, 0.02-0.5% allantoin, 0.3-0.6% phenoxyethanol, 0.1-0.5% potassium cetyl phosphate, 0.2-0.5% triethanolamine, 0.1-0.5% acrylic acid or ester/C10-30 alkanol acrylate crosspolymer, 0.1-0.4% caprylyl glycol, 0.05-0.2% of EDTA-disodium, 0.001-0.005% of sodium hyaluronate, 0.0001-0.02% of resveratrol, 0.0001-0.01% of rosa damascena flower extract, 0.1-0.2% of essence, 0.00001-0.00002% of colorant CI75470, 0.00003-0.00006% of colorant CI 15985, 0.00001-0.00003% of colorant CI19140 and 0.00001-0.00002% of colorant CI 17200;
the component B consists of arachidyl alcohol, behenyl alcohol and arachidyl glucoside, and accounts for 1-4% of the total;
the component C comprises 1-3% of a secondary fission yeast fermentation product filtrate, caprylyl hydroximic acid, propylene glycol, glyceryl caprylate and phenoxyethanol;
the component D comprises butanediol and hydrolytic yeast extract, accounting for 0.2-2% of the total;
the component E consists of hydroxyphenyl propionamide benzoic acid, ascorbyl palmitate, butanediol and 1, 2-pentanediol, and accounts for 0.1-0.5% of the total;
the component F comprises semen glycines extract and glycerol, and accounts for 0.05-0.5%;
the G component consists of euglena gracilis polysaccharide and hydrolyzed collagen, and accounts for 0.01-0.5% of the total;
the H component consists of water, palmitoyl oligopeptide, palmitoyl tetrapeptide-7, butanediol, carbomer, glycerol and polysorbate-20, and accounts for 0.001-0.5%;
the component I comprises water, hydrolyzed elastin, citric acid, tropolone, polysorbate-20, octyl glycol, ethylhexyl glycerol, and 1, 2-hexanediol, and accounts for 0.001-0.3%;
the J component consists of water, palmitoyl pentapeptide-4, glycerol, butanediol, carbomer and polysorbate-20, and accounts for 0.001-2%;
the component K consists of water, ceramide 3, caprylic/capric triglyceride, cholesterol, hydrogenated lecithin, phytosphingosine, stearic acid, oleic acid and lactic acid, and accounts for 0.001-0.5% of the total;
the L component comprises apple fruit cell culture extract, glycerol, lecithin, xanthan gum and phenoxyethanol, and accounts for 0.001-0.5% of the total;
the M component comprises water, butanediol, and Lac Regis Apis extract, and accounts for 0.001-0.2% of the total amount.
The sum of the components A to M is 100%.
3. The composition for lightening fine lines according to claims 1 and 2, wherein: the preferable components in the composition for fading fine lines are as follows in percentage by weight:
the component A comprises 54.435893% of water, 5% of dipropylene glycol, 4% of isohexadecane, 4% of caprylic/capric triglyceride, 3% of cocoglycerides, 2% of butanediol, 2% of propylene glycol, 2% of glycerol, 2% of stearyl alcohol, 2% of shea butter, 2% of mineral oil, 2% of polydimethylsiloxane, 1% of talcum powder, 1% of stearic acid, 1% of PEG-60 glyceryl isostearate, 1% of behenyl alcohol, 1% of glucosyl hesperidin, 0.5% of 1, 2-pentanediol, 0.5% of trehalose, 0.5% of silica, 0.5% of panthenol, 0.3% of cholesteryl hydroxy stearic acid ester, 0.3% of carnosine, 0.3% of tocopheryl acetate, 0.3% of allantoin, 0.3% of phenoxyethanol, 0.2% of cetyl alcohol phosphate, 0.2% of triethanolamine acrylate, 0.2% of acrylic acid ester 10% of cross-linked polymer of C30-32C-C.3% of acrylic acid, 0.2% of caprylyl glycol, 0.1% of EDTA-disodium, 0.003% of sodium hyaluronate, 0.0005% of resveratrol, 0.0005% of rosa damascena flower extract, 0.1% of essence, 0.00002% of colorant CI75470, 0.00003% of colorant CI 15985, 0.00001% of colorant CI19140 and 0.00001% of colorant CI 17200;
the component B consists of 0.5 percent of arachidyl alcohol, 0.5 percent of behenyl alcohol and 0.5 percent of arachidyl alcohol glucoside;
the component C comprises 0.01% of a fermentation product filtrate of the yeast schizosaccharomyces, 0.1% of caprylyl hydroximic acid, 1% of propylene glycol, 0.1% of glyceryl caprylate and 0.1% of phenoxyethanol;
the component D comprises 0.5% of butanediol and 0.1% of hydrolytic yeast extract;
the component E consists of 0.05 percent of hydroxyphenylpropionamide benzoic acid, 0.05 percent of ascorbyl palmitate, 0.1 percent of butanediol and 0.1 percent of 1, 2-pentanediol;
the component F comprises 0.05% of extract of semen glycines and 0.2% of glycerol;
the G component consists of 0.05 percent of euglena gracilis polysaccharide and 0.05 percent of hydrolyzed collagen;
the H component comprises 0.2% of water, 0.005% of palmitoyl oligopeptide, 0.005% of palmitoyl tetrapeptide-7, 0.005% of butanediol, 0.1% of carbomer, 0.1% of glycerol and 0.005% of polysorbate-20;
component I consists of 0.05% of water, 0.0005% of hydrolyzed elastin, 0.1% of citric acid, 0.0005% of tropolone, 0.005% of polysorbate-20, 0.02% of caprylyl glycol, 0.02% of ethylhexyl glycerin, 0.05% of 1, 2-hexanediol;
the J component consists of 0.5% of water, 0.005% of palmitoyl pentapeptide-4, 0.5% of glycerin, 0.005% of butanediol, 0.05% of carbomer and 0.05% of polysorbate-20;
the K component consists of 0.05 percent of water, 0.005 percent of ceramide 3, 0.05 percent of caprylic/capric triglyceride, 0.005 percent of cholesterol, 0.005 percent of hydrogenated lecithin, 0.005 percent of phytosphingosine, 0.01 percent of stearic acid, 0.01 percent of oleic acid and 0.01 percent of lactic acid;
the L component comprises 0.05% of apple fruit cell culture extract, 0.01% of glycerol, 0.01% of lecithin, 0.01% of xanthan gum and 0.01% of phenoxyethanol;
the M component comprises 0.1% of water, 0.05% of butanediol, and 0.01% of royal jelly extract.
4. A process for the preparation of a composition for lightening fine lines as claimed in any one of claims 1 to 3, characterized in that: the preparation method comprises the following steps:
1) weighing the component A into a water phase pot, stirring and heating;
2) weighing the components B to M, and respectively stirring and mixing for later use;
3) adding the component A, putting the mixture into an emulsifying pot, vacuumizing, stirring and emulsifying; after vacuum emulsification, stirring and cooling are started, and B, C, D, E items are added; stirring and cooling after vacuum stirring; adding F, G, H, I, J, K, L, M components, vacuum emulsifying, and discharging.
5. The method of claim 4, wherein: adding the component A, stirring and heating to 80-85 ℃, placing in an emulsifying pot, vacuumizing to 500pa, stirring at 20rpm, emulsifying at 3200rpm, after vacuum emulsification for 5 minutes, beginning to stir, cooling to 50 ℃, adding B, C, D, E items, after vacuum stirring for 3 minutes, stirring, cooling to 40 ℃, adding the component F, G, H, I, J, K, L, M, and performing vacuum emulsification for 2 minutes, thus obtaining the material.
6. A skin care product characterized by: the composition for fading fine lines as claimed in any one of claims 1 to 3 is added to the skin care product.
7. A skin care product according to claim 6, characterized in that: the skin care product is selected from any one of eye cream and eye patch.
CN201911017454.9A 2019-10-24 2019-10-24 Composition for fading fine lines Pending CN110787074A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911017454.9A CN110787074A (en) 2019-10-24 2019-10-24 Composition for fading fine lines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911017454.9A CN110787074A (en) 2019-10-24 2019-10-24 Composition for fading fine lines

Publications (1)

Publication Number Publication Date
CN110787074A true CN110787074A (en) 2020-02-14

Family

ID=69441282

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911017454.9A Pending CN110787074A (en) 2019-10-24 2019-10-24 Composition for fading fine lines

Country Status (1)

Country Link
CN (1) CN110787074A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111214418A (en) * 2020-03-13 2020-06-02 佛山市奥姿美生物科技有限公司 Efficient barrier repair composition and application thereof
CN113304065A (en) * 2021-05-08 2021-08-27 广州宝思利生物科技有限公司 Scalp care composition and application thereof
EP4059488A1 (en) * 2021-03-19 2022-09-21 Johnson & Johnson Consumer Inc. Concentrated composition and uses of same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
安婕妤化妆品科技股份有限公司: "安婕妤臻美无龄眼霜(升级版)", 《国产非特殊用途化妆品备案服务平台》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111214418A (en) * 2020-03-13 2020-06-02 佛山市奥姿美生物科技有限公司 Efficient barrier repair composition and application thereof
EP4059488A1 (en) * 2021-03-19 2022-09-21 Johnson & Johnson Consumer Inc. Concentrated composition and uses of same
WO2022195404A1 (en) * 2021-03-19 2022-09-22 Johnson & Johnson Consumer Inc. Concentrated composition and uses of same
CN113304065A (en) * 2021-05-08 2021-08-27 广州宝思利生物科技有限公司 Scalp care composition and application thereof

Similar Documents

Publication Publication Date Title
CN110731923B (en) Enhanced moisturizing cosmetic compositions
CN105769666B (en) A kind of composition and the skin care item containing said composition
JP2021020887A (en) Enhanced anti-aging cosmetic composition
CN110731928A (en) Anti-aging cosmetic composition
CN110787074A (en) Composition for fading fine lines
CN110742852A (en) Composition for multi-effect repair of sensitive skin and preparation method and application thereof
CN109381356A (en) A kind of sleep late frost and preparation method thereof
CN115607499B (en) Ginseng ganoderma lucidum polypeptide composition for resisting wrinkle and compacting and application thereof
CN110721120A (en) Multifunctional skin care cream and preparation method thereof
CN114848520B (en) Whitening and repairing composition and application thereof
CN114848542A (en) Black truffle cosmetic composition, black truffle face cream and preparation method thereof
CN111557892A (en) Cosmetic composition containing prebiotics
CN115252516A (en) Water-feeling blush and preparation method thereof
CN110812262A (en) Anti-wrinkle firming composition
CN109260086B (en) Anti-wrinkle essence, preparation method and application thereof
CN116637042A (en) Wrinkle-removing anti-aging skin care product and preparation method and application thereof
CN114288201B (en) Composition for removing pouch and fading black eye, and preparation method and application thereof
CN110302117A (en) Compact shining face essence cream of one kind and preparation method thereof
CN110585080A (en) Skin care product containing cracked yeast cell wall-broken extract
CN111773151B (en) Whitening and freckle-removing antioxidant emulsion and preparation method thereof
CN113197809B (en) Preparation method of skin care product containing phaeodactylum and tara fermentation compound
CN114159333A (en) Muscle foundation liquid and preparation method thereof
CN112933010A (en) Whitening and repairing cream and preparation method thereof
CN112773732A (en) Moisturizing repair cream containing fibroin and preparation method thereof
CN111467269A (en) Health product containing Tuber summer fungus extract and its preparation method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200214